Peter Steelman

Peter Steelman was a Partner at Deerfield Management, a leading healthcare investment firm based in New York, where he played an instrumental role in building the firm's academic network and advancing its investment strategy in the healthcare sector. His responsibilities included identifying and supporting cutting-edge therapeutic innovation, particularly in biotechnology and life sciences, with a notable emphasis on hematological malignancies such as acute myeloid leukemia (AML).

Prior to joining Deerfield in 2016, Peter served as President and CEO of FSC Laboratories, Inc., overseeing operations and strategic direction for over a decade. Earlier in his career, he was Managing Director at Wachovia Securities, bringing substantial expertise in finance and capital markets to his roles in life sciences investing.

Peter held a Master of Business Administration from Columbia Business School and a Bachelor of Arts from DePauw University, reflecting a strong foundation in both business and liberal arts. His legacy at Deerfield is honored through the ASH Peter Steelman Scholar Award, which supports pioneering research in hematology and underscores his enduring impact on healthcare innovation and investment.